Literature DB >> 21212371

The value of MR imaging when the site of uterine cancer origin is uncertain.

Hebert Alberto Vargas1, Oguz Akin, Junting Zheng, Chaya Moskowitz, Robert Soslow, Nadeem Abu-Rustum, Richard R Barakat, Hedvig Hricak.   

Abstract

PURPOSE: To assess the value of magnetic resonance (MR) imaging in determining the site of origin of newly diagnosed uterine cancer (corpus vs cervix) when clinical and/or histologic evaluation is indeterminate.
MATERIALS AND METHODS: The Institutional Review Board approved and waived informed consent for this HIPAA-compliant study of 59 women (median age, 59 years; range, 28-84 years) who underwent pelvic MR imaging to determine the anatomic origin of uterine cancer. Two radiologists independently retrospectively assessed all MR imaging studies. In 48 patients who underwent hysterectomy, surgical pathologic findings were the reference standard, and overall test yields and diagnostic likelihood ratios were measured. Accuracy in detecting invasion of adjacent structures was also calculated. For the remaining patients, imaging and biopsy findings are presented descriptively.
RESULTS: At hysterectomy, 32 patients had uterine corpus cancer and 16 had cervical cancer. Overall test yields for reader 1 and reader 2 were 0.85 and 0.88, respectively. When a reader attributed a tumor's origin to either the uterine corpus or cervix, the odds of the tumor originating from that site were 4.80-6.35 times greater than they would have been if no other information were available. Accuracy levels in detecting invasion of the myometrium, cervical stroma, parametria and/or adnexae, and vagina, respectively, were 72%, 69%, 74%, and 85% for reader 1 and 78%, 77%, 76%, and 85% for reader 2.
CONCLUSION: MR imaging is useful for determining the anatomic origin of uterine cancer and provides helpful information regarding invasion of adjacent structures. © RSNA, 2011.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212371      PMCID: PMC6939956          DOI: 10.1148/radiol.10101147

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  23 in total

1.  Endometrial carcinoma: dynamic MRI with turbo-FLASH technique.

Authors:  I Joja; M Asakawa; T Asakawa; T Nakagawa; S Kanazawa; M Kuroda; I Togami; Y Hiraki; N Akamatsu; T Kudo
Journal:  J Comput Assist Tomogr       Date:  1996 Nov-Dec       Impact factor: 1.826

2.  Uterine cervical carcinoma: preoperative staging with 3.0-T MR imaging--comparison with 1.5-T MR imaging.

Authors:  Masatoshi Hori; Tonsok Kim; Takamichi Murakami; Izumi Imaoka; Hiromitsu Onishi; Kaname Tomoda; Tateki Tsutsui; Takayuki Enomoto; Tadashi Kimura; Hironobu Nakamura
Journal:  Radiology       Date:  2009-02-12       Impact factor: 11.105

3.  Intermediate, indeterminate, and uninterpretable diagnostic test results.

Authors:  D L Simel; J R Feussner; E R DeLong; D B Matchar
Journal:  Med Decis Making       Date:  1987 Apr-Jun       Impact factor: 2.583

Review 4.  Imaging of endometrial adenocarcinoma.

Authors:  T D Barwick; A G Rockall; D P Barton; S A Sohaib
Journal:  Clin Radiol       Date:  2006-07       Impact factor: 2.350

5.  Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study.

Authors:  Diego H Castrillon; Kenneth R Lee; Marisa R Nucci
Journal:  Int J Gynecol Pathol       Date:  2002-01       Impact factor: 2.762

6.  A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.

Authors:  W Glenn McCluggage; V Palaniappan Sumathi; Hilary A McBride; Anna Patterson
Journal:  Int J Gynecol Pathol       Date:  2002-01       Impact factor: 2.762

7.  Endometrial carcinoma staging by MR imaging.

Authors:  H Hricak; J L Stern; M R Fisher; L G Shapeero; M L Winkler; C G Lacey
Journal:  Radiology       Date:  1987-02       Impact factor: 11.105

8.  p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma.

Authors:  W G McCluggage; D Jenkins
Journal:  Int J Gynecol Pathol       Date:  2003-07       Impact factor: 2.762

9.  Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning.

Authors:  Riccardo Manfredi; Paoletta Mirk; Giulia Maresca; Pasquale A Margariti; Antonia Testa; Gian Franco Zannoni; Deborah Giordano; Giovanni Scambia; Pasquale Marano
Journal:  Radiology       Date:  2004-03-18       Impact factor: 11.105

10.  Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint.

Authors:  Seiryu Kamoi; Muna I AlJuboury; Marie-Rose Akin; Steven G Silverberg
Journal:  Int J Gynecol Pathol       Date:  2002-07       Impact factor: 2.762

View more
  7 in total

Review 1.  Current imaging strategies for the evaluation of uterine cervical cancer.

Authors:  Charis Bourgioti; Konstantinos Chatoupis; Lia Angela Moulopoulos
Journal:  World J Radiol       Date:  2016-04-28

2.  Can magnetic resonance spectroscopy differentiate endometrial cancer?

Authors:  Jie Zhang; Shifeng Cai; Changzhong Li; Xichao Sun; Xue Han; Chunrun Yang; Caixia Fu; Qingwei Liu; Yinghui Xin; Yuanyuan Zong
Journal:  Eur Radiol       Date:  2014-06-06       Impact factor: 5.315

3.  Role of MRI in diagnosing the primary site of origin in indeterminate cases of uterocervical carcinomas: a systematic review and meta-analysis.

Authors:  Pooja Jain; Ankita Aggarwal; Rohini Gupta Ghasi; Amita Malik; Ritu Nair Misra; Kanwaljeet Garg
Journal:  Br J Radiol       Date:  2021-10-28       Impact factor: 3.039

4.  Imaging across the life span: innovations in imaging and therapy for gynecologic cancer.

Authors:  Meng Xu-Welliver; William T C Yuh; Julia R Fielding; Katarzyna J Macura; Zhibin Huang; Ahmet S Ayan; Floor J Backes; Guang Jia; Mariam Moshiri; Jun Zhang; Nina A Mayr
Journal:  Radiographics       Date:  2014 Jul-Aug       Impact factor: 5.333

Review 5.  MRI of the endometrium - from normal appearances to rare pathology.

Authors:  Roxana Pintican; Vlad Bura; Marta Zerunian; Janette Smith; Helen Addley; Susan Freeman; Damiano Caruso; Andrea Laghi; Evis Sala; Mercedes Jimenez-Linan
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.629

Review 6.  MRI of endometrium cancer - how we do it.

Authors:  Matthias Meissnitzer; Rosemarie Forstner
Journal:  Cancer Imaging       Date:  2016-05-09       Impact factor: 3.909

7.  Comparison of optimised endovaginal vs external array coil T2-weighted and diffusion-weighted imaging techniques for detecting suspected early stage (IA/IB1) uterine cervical cancer.

Authors:  Kate Downey; Ayoma D Attygalle; Veronica A Morgan; Sharon L Giles; A MacDonald; M Davis; Thomas E J Ind; John H Shepherd; Nandita M deSouza
Journal:  Eur Radiol       Date:  2015-07-11       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.